ArticleJournal of hematology & oncology2021

Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.

Joaquin Martinez-Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.